Cytokinetics Inc - ESG Rating & Company Profile powered by AI
Comprehensive ESG analysis of Cytokinetics Inc can be accessed by signing up for free. If you are employed by Cytokinetics Inc and you would like to licence your Sustainability aseessment, please get in touch. The SDG score for Cytokinetics Inc represents its reporting of the United Nations SDGs.
Cytokinetics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 1.1, social score of 6.0 and governance score of 6.0.
5.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 999 | Xeris Pharmaceuticals Inc | 5.1 | High |
| 999 | Vascular Biogenics Ltd | 5.1 | High |
| 1047 | Cytokinetics Inc | 5.0 | High |
| 1047 | Anixa Biosciences Inc | 5.0 | High |
| 1047 | Amarin Corporation PLC | 5.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cytokinetics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cytokinetics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Cytokinetics Inc report the average age of the workforce?
Sign up for free to unlockDoes Cytokinetics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cytokinetics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cytokinetics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Cytokinetics Inc offer flexible work?
Sign up for free to unlockDoes Cytokinetics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cytokinetics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cytokinetics Inc conduct supply chain audits?
Sign up for free to unlockDoes Cytokinetics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cytokinetics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cytokinetics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cytokinetics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cytokinetics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cytokinetics Inc disclose water use targets?
Sign up for free to unlockDoes Cytokinetics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Cytokinetics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Cytokinetics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Cytokinetics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cytokinetics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cytokinetics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Cytokinetics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cytokinetics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cytokinetics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cytokinetics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cytokinetics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cytokinetics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cytokinetics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Cytokinetics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cytokinetics Inc disclose its waste policy?
Sign up for free to unlockDoes Cytokinetics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Cytokinetics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cytokinetics Inc disclose energy use targets?
Sign up for free to unlockDoes Cytokinetics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cytokinetics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cytokinetics Inc
These potential risks are based on the size, segment and geographies of the company.
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy; and CK-3772271, a small molecule cardiac myosin inhibitor that is in Phase I clinical trial. Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The company was incorporated in 1997 and is headquartered in South San Francisco, California.